· 2019-09-23 · graybug vision inc. biotechnology - therapeutics and diagnostics 80.00 series c...
Post on 22-Jun-2020
1 Views
Preview:
TRANSCRIPT
Company Name
Sector Amount (in Million USD)
Type of Round
Financing Stage
Ownership Country
Just Medical Co. Ltd.
Medical Technology
14.50 Series A / 1. Round
Equity (private)
Private / independent
China (Mainland)
IotaMotion Inc Medical Technology
2.52 Other Other Private / independent
USA
HiFiBiO SAS Biotechnology - Therapeutics and
Diagnostics
67.00 Series C / 3. Round
Equity (private)
Private / independent
France
Unibio A/S Biotechnology - other
15.00 UD Equity (private)
Private / independent
Denmark
OncoNano Medicine Inc.
Biotechnology - Therapeutics and
Diagnostics
15.40 Other Research grants
Private / independent
USA
EBR Systems Inc.
Medical Technology
30.00 Other Other Private / independent
USA
Boston Microfluidics
Biotechnology / R&D Services
17.50 Series A / 1. Round
Equity (private)
Private / independent
USA
ESSA Pharma Inc.
Biotechnology - Therapeutics and
Diagnostics
36.00 Other Post-IPO Publicly listed on
stock exchange
Canada
E25Bio Inc. Biotechnology / R&D Services
2.30 Other Other Private / independent
USA
Emtora Biosciences
Biotechnology - Therapeutics and
Diagnostics
3.00 Series G / 7. Round
Research grants
Private / independent
USA
Continuus Pharmaceuticals
Biotechnology / R&D Services
5.00 Series B / 2. Round
UD Private / independent
USA
Finch Therapeutics Group Inc.
Biotechnology - Therapeutics and
Diagnostics
53.00 Series C / 3. Round
Equity (private)
Private / independent
USA
Chinook Therapeutics Inc.
Biotechnology - Therapeutics and
Diagnostics
65.00 Series A / 1. Round
Equity (private)
Private / independent
Canada
ONL Therapeutics Inc.
Biotechnology - Therapeutics and
Diagnostics
3.00 Other UD Private / independent
USA
Aperiomics Inc. Biotechnology / R&D Services
1.80 Series A / 1. Round
Equity (private)
Private / independent
USA
Bellicum Pharmaceuticals Inc.
Biotechnology - Therapeutics and
Diagnostics
57.50 Other Post-IPO Publicly listed on
stock exchange
USA
Oncorus Inc. Biotechnology - Therapeutics and
Diagnostics
79.50 Series B / 2. Round
Equity (private)
Private / independent
USA
Rexgenero Limited
Biotechnology - Therapeutics and
Diagnostics
0.33 Other Research grants
Private / independent
United Kingdom
Helix Biopharma Corp.
Biotechnology - Therapeutics and
Diagnostics
7.00 Other UD Publicly listed on
stock exchange
Canada
Altimmune Inc. Biotechnology - Therapeutics and
Diagnostics
3.70 Other Research grants
Publicly listed on
stock exchange
USA
Delcath Systems Inc.
Pharma 9.50 Other Other Publicly listed on
stock exchange
USA
Graybug Vision Inc.
Biotechnology - Therapeutics and
Diagnostics
80.00 Series C / 3. Round
Other Private / independent
USA
Vaxxilon AG Biotechnology - Therapeutics and
Diagnostics
1.40 Other Research grants
Private / independent
Switzerland
Araris Biotech AG
Biotechnology - Therapeutics and
Diagnostics
2.53 UD Equity (private)
Private / independent
Switzerland
Juvenescence Limited
Biotechnology - Therapeutics and
Diagnostics
100.00 Series B / 2. Round
Equity (private)
Private / independent
Isle of Man
Yaoyanshe (Shanghai Mudi Biological Technology Co.Ltd.)
Biotechnology / R&D Services
42.00 Series C / 3. Round
Equity (private)
Private / independent
China (Mainland)
Soligenix Inc. Biotechnology - Therapeutics and
Diagnostics
0.15 Other Research grants
Publicly listed on
USA
stock exchange
NOXXON Pharma N.V
Biotechnology - Therapeutics and
Diagnostics
1.10 Other Post-IPO Publicly listed on
stock exchange
Germany
Monopar Therapeutics Inc.
Biotechnology - Therapeutics and
Diagnostics
40.00 Other IPO Private / independent
USA
Motif FoodWorks Inc.
Biotechnology - other
27.50 Other Other Private / independent
USA
XpectVision Technology Co. Ltd.
Medical Technology
14.00 Series B / 2. Round
Equity (private)
Private / independent
China (Mainland)
AtriCure Inc. Medical Technology
300.00 Other Other Publicly listed on
stock exchange
USA
Deciphera Pharmaceuticals Inc.
Biotechnology - Therapeutics and
Diagnostics
400.00 Other Post-IPO Publicly listed on
stock exchange
USA
Tevosol Inc. Medical Technology
1.50 Other Other Private / independent
Canada
D&D Pharmatech
Biotechnology - Therapeutics and
Diagnostics
137.10 Series B / 2. Round
Other Private / independent
South Korea
DelMar Pharmaceuticals Inc.
Biotechnology - Therapeutics and
Diagnostics
6.70 Other Post-IPO Publicly listed on
stock exchange
USA
Antibe Therapeutics Inc.
Biotechnology - Therapeutics and
Diagnostics
8.00 Other Post-IPO Publicly listed on
stock exchange
Canada
Apollo Endosurgery Inc.
Medical Technology
20.00 Other Debt financing
Publicly listed on
stock exchange
USA
Mustang Bio Biotechnology - Therapeutics and
Diagnostics
9.28 Other UD Publicly listed on
stock exchange
USA
RESPIRIX INC. Medical Technology
1.30 Other Other Private / independent
USA
Landos Biopharma Inc.
Biotechnology - Therapeutics and
Diagnostics
60.00 Series B / 2. Round
Equity (private)
Private / independent
USA
Dynavax Technologies Corporation
Biotechnology - Therapeutics and
Diagnostics
70.10 Other Post-IPO Publicly listed on
stock exchange
USA
InMode Ltd. Medical Technology
70.00 Other IPO Publicly listed on
stock exchange
Israel
Hazel Technologies Inc.
Biotechnology - other
13.00 Other Other Private / independent
USA
CardioMech AS Medical Technology
5.00 Other Convertible loan
Private / independent
Norway
AgroSavfe NV Biotechnology - other
38.65 Series C / 3. Round
Equity (private)
Private / independent
Belgium
Beijing Baicare Biotechnology Co. Ltd.
Biotechnology - Therapeutics and
Diagnostics
9.00 Series B / 2. Round
Equity (private)
Private / independent
China (Mainland)
Novosteo Inc. Biotechnology - Therapeutics and
Diagnostics
0.50 Other Equity (private)
Private / independent
USA
Quanterix Corporation
Biotechnology / R&D Services
60.00 Other UD Publicly listed on
stock exchange
USA
Kangpu Bio-Pharmaceutical Technology (Shanghai) Co. Ltd.
Biotechnology - Therapeutics and
Diagnostics
14.00 Series A / 1. Round
Equity (private)
Private / independent
China (Mainland)
NovaBay Pharmaceuticals Inc.
Biotechnology - Therapeutics and
Diagnostics
2.70 Other Post-IPO Publicly listed on
stock exchange
USA
NovaBay Pharmaceuticals Inc.
Biotechnology - Therapeutics and
Diagnostics
4.20 Other Post-IPO Publicly listed on
stock exchange
USA
SHINE Medical Technologies Inc
Medical Technology
15.00 Other Research grants
Private / independent
USA
Numerate Inc Biotechnology - Therapeutics and
Diagnostics
2.00 Other Research grants
Private / independent
USA
Stemline Therapeutics Inc.
Biotechnology - Therapeutics and
Diagnostics
76.20 Other Post-IPO Publicly listed on
stock exchange
USA
Oric Pharmaceuticals Inc.
Biotechnology - Therapeutics and
Diagnostics
55.00 Series D / 4. Round
Equity (private)
Private / independent
USA
Glycomine Inc. Biotechnology - Therapeutics and
Diagnostics
33.00 Series B / 2. Round
Other Private / independent
USA
Biosignatures Ltd
Biotechnology / R&D Services
4.27 Other Equity (private)
Private / independent
United Kingdom
AIQ Solutions Medical Technology
3.20 Series A / 1. Round
Other Private / independent
USA
ObsEva SA Pharma 75.00 Other Other Publicly listed on
stock exchange
Switzerland
RoosterBio Inc. Biotechnology / R&D Services
15.00 Series B / 2. Round
Equity (private)
Private / independent
USA
SpeeDx Pty. Ltd. Biotechnology / R&D Services
UD Other Equity (private)
Private / independent
Australia
Kineta Inc. Biotechnology - Therapeutics and
Diagnostics
1.80 Other Other Private / independent
USA
Forty Seven Inc. Biotechnology - Therapeutics and
Diagnostics
6.00 Other Research grants
Publicly listed on
stock exchange
USA
Kane Biotech Inc.
Medical Technology
3.80 Other UD Publicly listed on
stock exchange
Canada
Inovio Pharmaceuticals Inc.
Biotechnology - Therapeutics and
Diagnostics
15.00 Other Post-IPO Publicly listed on
stock exchange
USA
Obalon Therapeutics Inc.
Medical Technology
16.60 Other Post-IPO Publicly listed on
stock exchange
USA
Cleave Therapeutics Inc.
Biotechnology - Therapeutics and
Diagnostics
12.00 Other Equity (private)
Private / independent
USA
Advantagene Inc.
Biotechnology - Therapeutics and
Diagnostics
2.00 Other Research grants
Private / independent
USA
Inari Agriculture Biotechnology - other
89.00 Series C / 3. Round
Equity (private)
Subsidiary USA
Lucira Health Inc.
Biotechnology / R&D Services
15.00 Series B / 2. Round
Equity (private)
Private / independent
USA
Sagimet Biosciences
Biotechnology - Therapeutics and
Diagnostics
7.00 Series E / 5. Round
Equity (private)
Private / independent
USA
AlphaTech Biotechnology / R&D Services
57.70 Other Other Private / independent
USA
GNA Biosolutions GmbH
Biotechnology / R&D Services
13.50 Series C / 3. Round
UD Private / independent
Germany
Exo Imaging Inc. Medical Technology
35.00 Series B / 2. Round
Other Private / independent
USA
BioCardia Inc. Medical Technology
10.00 Other IPO Publicly listed on
stock exchange
USA
Arcturus Therapeutics Ltd.
Biotechnology - Therapeutics and
Diagnostics
2.30 Other UD Publicly listed on
stock exchange
USA
Exicure Inc. Biotechnology - Therapeutics and
Diagnostics
63.25 Other IPO Publicly listed on
stock exchange
USA
Exicure Inc. Biotechnology - Therapeutics and
Diagnostics
63.25 Other Post-IPO Publicly listed on
stock exchange
USA
Abcuro Inc. Biotechnology - Therapeutics and
Diagnostics
8.00 Series A / 1. Round
Other Private / independent
USA
Anokion US Inc. Biotechnology - Therapeutics and
Diagnostics
0.00 Series B / 2. Round
Equity (private)
Private / independent
USA
Rewind Therapeutics
Biotechnology - Therapeutics and
Diagnostics
3.20 Other Research grants
Private / independent
Belgium
Prokaryotics Inc.
Biotechnology - Therapeutics and
Diagnostics
2.30 Other Research grants
Private / independent
USA
ImCheck Therapeutics S.A.S
Biotechnology - Therapeutics and
Diagnostics
2.21 Other UD Private / independent
France
Alize Pharma 3 Biotechnology - Therapeutics and
Diagnostics
74.73 Series A / 1. Round
UD Private / independent
France
top related